joint injections peoria: what can ease the soreness

Joint soreness can change each day

Arthritis often brings aching and stiffness. A past injury can also bother your knee, hip or shoulder. A tendon is a firm cord linking a muscle with bone. That cord can get sore after extra work. Sleep, movement and rest can all change the ache. One rough day doesn't prove the joint got worse.

You'll want to note when it starts and the motion that brings it on.

Gentle movement can calm a mild flare

Stop when an ache turns sharp. Shorten the chore, rest awhile and try again more gently. Regular exercise can help you keep strength and movement. A brace or pain medicine may also fit your health. Check medicines with your doctor, since other pills can change what's safe. If body weight adds strain, even a small change may help.

You won't need to finish every chore on a sore day.

Lasting soreness deserves an exam

Call an office when the ache disturbs sleep or routine chores. An exam may not answer every question on its own. Bring old X-ray notes, records from earlier shots and your medicine list, then say when the ache began and show the exact movement that hurts most during your usual day. Name anything that helped. You'll hear whether exercise, medicine, a brace, a shot or surgery might fit.

Ask about cost, time and the next choice if care doesn't help.

Sources

1. A meta-analysis of 14 placebo cohorts (1,076 patients) found intra-articular NORMAL SALINE alone produced statistically and clinically meaningful improvement in VAS pain and WOMAC scores lasting up to 6 months - meaning a large share of the improvement people attribute to an injection is not attributable to the drug in the syringe.

   Saltzman BM, et al. — The Therapeutic Effect of Intra-articular Normal Saline Injections for Knee Osteoarthritis: A Meta-analysis of Evidence Level 1 Studies.. Am J Sports Med, 2017. DOI: 10.1177/0363546516680607.

2. A meta-analysis of 50 studies (4,076 patients) quantified the placebo effect of knee injections as significant and long-lasting, with functional improvements persisting even longer than the improvements in pain perception, and warned that the size of this effect should not be overlooked when interpreting trials or counselling patients.

   Previtali D, et al. — The Long-Lasting Effects of "Placebo Injections" in Knee Osteoarthritis: A Meta-Analysis.. Cartilage, 2021. DOI: 10.1177/1947603520906597.

3. A network meta-analysis of pharmacologic knee OA treatments found intra-articular treatments were superior to oral NSAIDs, and the authors attributed this at least partly to the integrated placebo effect of the injection itself rather than to the injected substance.

   Bannuru RR, et al. — Comparative effectiveness of pharmacologic interventions for knee osteoarthritis: a systematic review and network meta-analysis.. Ann Intern Med, 2015. DOI: 10.7326/M14-1231.

4. A qualitative study interviewing 38 patients and 19 primary care clinicians found patients valued injections as an alternative to treatments they found undesirable, but reported wide variation in access, in onset and in how long the effect lasted; clinicians described an overarching theme of 'caution and competence', including uncertainty about the evidence and guidelines and the possibility of placebo.

   Moore AJ, et al. — Intra-articular corticosteroid injections for osteoarthritis: A qualitative study of patients' and clinicians' experiences.. PLoS One, 2024. DOI: 10.1371/journal.pone.0311668.

5. The RESTORE randomized trial (288 participants, leukocyte-poor PRP, 3 weekly injections) found no significant difference from saline placebo at 12 months in knee pain (-2.1 vs -1.8 points; difference -0.4, 95% CI -0.9 to 0.2) or in medial tibial cartilage volume (-1.4% vs -1.2%), with 29 of 31 secondary outcomes also showing no between-group difference.

   Bennell KL, et al. — Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis: The RESTORE Randomized Clinical Trial.. JAMA, 2021. DOI: 10.1001/jama.2021.19415.

6. A 2022 BMJ systematic review and meta-analysis of 169 trials (21,163 participants) found viscosupplementation produced only a small pain reduction versus placebo (SMD -0.08, 95% CI -0.15 to -0.02; about -2.0 mm on a 100 mm VAS), below the minimal clinically important difference, and trial sequential analysis indicated conclusive evidence of clinical equivalence with placebo since 2009.

   Pereira TV, et al. — Viscosupplementation for knee osteoarthritis: systematic review and meta-analysis.. BMJ, 2022. DOI: 10.1136/bmj-2022-069722.

7. The 2015 Cochrane review of 27 trials (1,767 participants) found intra-articular corticosteroid better than sham for knee OA pain (SMD -0.40, 95% CI -0.58 to -0.22; NNTB 8), but the benefit decayed with time: moderate at 1-2 weeks, small at 13 weeks, and no evidence of any effect at 26 weeks. All outcomes were graded LOW quality.

   Jüni P, et al. — Intra-articular corticosteroid for knee osteoarthritis.. Cochrane Database Syst Rev, 2015. DOI: 10.1002/14651858.CD005328.pub3.